Skip to main content

Advertisement

Table 2 Comorbidity disease and CCI score

From: Correlation between the Charlson comorbidity index and skeletal muscle mass/physical performance in hospitalized older people potentially suffering from sarcopenia

 All(n = 168)Men(n = 99)Women(n = 69)
Comorbidity disease, n (%)
 MI22 (13.10)13 (13.13)9 (13.04)
 CHD20 (11.90)17 (17.17)3 (4.35)
 PAOD6 (3.57)3 (3.03)3 (4.35)
 CVD98 (58.33)68 (68.69)30 (43.48)
 SD11 (6.55)2 (2.02)9 (13.04)
 COPD20 (11.90)11 (11.11)9 (13.04)
 CTD6 (3.57)0 (0)6 (8.70)
 GU49 (29.17)31 (31.31)18 (26.09)
 DM65 (38.69)50 (50.51)15 (21.74)
 CKD22 (13.10)13 (13.13)9 (13.04)
 HP2 (1.19)2 (2.02)0 (0)
 CL0 (0)0 (0)0 (0)
 ML1 (0.60)1 (1.01)0 (0)
 tumor49 (29.17)28 (28.28)21 (30.43)
 LD14 (8.33)11 (11.11)3 (4.35)
CCI score, n (%)
 411 (6.55)47
 533 (19.64)726
 654 (32.14)3321
 724 (14.29)213
 822 (13.10)220
 97 (4.17)43
 103 (1.79)30
 115 (2.98)23
 128 (4.76)26
 131 (0.60)10
  1. MI Miocardial infarction, CHD Chronic heart failure, PAOD Peripheral arterial obstructive disease, CVD Cerebral vascular disease, SD Senile dementia, COPD Chronic obstructive pulmonary disease, CTD Connective tissue disease, GU Gastroduodenal ulcer, DM Diabetes mellitus, CKD Chronic kidney disease, HP Hemiplegic paralysis, CL Chronic leukemia, ML malignant lymphadenoma, LD Liver disease